Literature DB >> 15101397

Salmonella infections in the mouse model: host resistance factors and in vivo dynamics of bacterial spread and distribution in the tissues.

Pietro Mastroeni1, Mark Sheppard.   

Abstract

The mouse model is widely used to study the mechanisms of the pathogenesis of, and immunity to, systemic salmonellosis. During infection, Salmonella grows in phagocytic cells that reside in well-defined pathological lesions, are activated by cytokines and control the growth of intracellular bacteria using oxygen and nitrogen derivatives. Salmonella growth in the tissues results in the spatial segregation of bacterial populations and in their continuous distribution to new phagocytes. High bacterial numbers within infected phagocytes are uncommon in vivo.

Entities:  

Mesh:

Year:  2004        PMID: 15101397     DOI: 10.1016/j.micinf.2003.12.009

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  40 in total

1.  Role for neutrophils in host immune responses and genetic factors that modulate resistance to Salmonella enterica serovar typhimurium in the inbred mouse strain SPRET/Ei.

Authors:  Lien Dejager; Iris Pinheiro; Pieter Bogaert; Liesbeth Huys; Claude Libert
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

Review 2.  Salmonella: from pathogenesis to therapeutics.

Authors:  Erin C Boyle; Jennifer L Bishop; Guntram A Grassl; B Brett Finlay
Journal:  J Bacteriol       Date:  2006-12-22       Impact factor: 3.490

Review 3.  A dynamic view of the spread and intracellular distribution of Salmonella enterica.

Authors:  Pietro Mastroeni; Andrew Grant; Olivier Restif; Duncan Maskell
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

Review 4.  Animal Models for Salmonellosis: Applications in Vaccine Research.

Authors:  Ellen E Higginson; Raphael Simon; Sharon M Tennant
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

5.  Salmonella-induced filament formation is a dynamic phenotype induced by rapidly replicating Salmonella enterica serovar typhimurium in epithelial cells.

Authors:  Cheryl L Birmingham; Xiuju Jiang; Maikke B Ohlson; Samuel I Miller; John H Brumell
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Toll-like receptor 4 signalling through MyD88 is essential to control Salmonella enterica serovar typhimurium infection, but not for the initiation of bacterial clearance.

Authors:  Suzanne Talbot; Sabine Tötemeyer; Masahiro Yamamoto; Shizuo Akira; Katherine Hughes; David Gray; Tom Barr; Pietro Mastroeni; Duncan J Maskell; Clare E Bryant
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

7.  Caspase-3-dependent phagocyte death during systemic Salmonella enterica serovar Typhimurium infection of mice.

Authors:  Andrew J Grant; Mark Sheppard; Rob Deardon; Sam P Brown; Gemma Foster; Clare E Bryant; Duncan J Maskell; Pietro Mastroeni
Journal:  Immunology       Date:  2008-02-20       Impact factor: 7.397

8.  Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice.

Authors:  Onyinye I Iweala; Donald W Smith; Kabir S Matharu; Isabel Sada-Ovalle; Deanna D Nguyen; Rosemarie H Dekruyff; Dale T Umetsu; Samuel M Behar; Cathryn R Nagler
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

9.  Comprehensive identification of Salmonella enterica serovar typhimurium genes required for infection of BALB/c mice.

Authors:  Roy R Chaudhuri; Sarah E Peters; Stephen J Pleasance; Helen Northen; Chrissie Willers; Gavin K Paterson; Danielle B Cone; Andrew G Allen; Paul J Owen; Gil Shalom; Dov J Stekel; Ian G Charles; Duncan J Maskell
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

10.  Dexamethasone modulates Salmonella enterica serovar Typhimurium infection in vivo independently of the glucocorticoid-inducible protein annexin-A1.

Authors:  Tomoko Smyth; Sabine Tötemeyer; Sean Haugland; Chrissie Willers; Sarah Peters; Duncan Maskell; Clare Bryant
Journal:  FEMS Immunol Med Microbiol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.